Thyroid Accumulation of 99m Tc-DTPA in Graves Disease

Clin Nucl Med. 2023 Nov 1;48(11):e552-e553. doi: 10.1097/RLU.0000000000004858. Epub 2023 Sep 7.

Abstract

99m Tc-DTPA dynamic renal scintigraphy for evaluating glomerular filtration rate was performed in a 29-year-old woman with hyperuricemia and Graves disease. Subsequently, 99m Tc-DTPA orbital scintigraphy was conducted to determine the activity of Graves ophthalmopathy. Thyroid accumulation of 99m Tc-DTPA was incidentally identified. This should be cautiously distinguished from 99m Tc-pertechnetate uptake, considering that the salivary glands, oral cavity, and stomach were not visualized. Our case demonstrates that augmentation of blood supply, enhancement of capillary permeability, and accumulation of inflammatory exudate may be involved in the pathological process of Graves disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Graves Disease* / diagnostic imaging
  • Humans
  • Radiopharmaceuticals
  • Sodium Pertechnetate Tc 99m
  • Technetium
  • Technetium Tc 99m Pentetate*
  • Tomography, X-Ray Computed

Substances

  • Technetium Tc 99m Pentetate
  • Radiopharmaceuticals
  • Technetium
  • Sodium Pertechnetate Tc 99m